clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Personalized Medicine
News & Features
News & Features
Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery
Bioinformatics
Study of Multiethnic Groups Reveals 27 New Disease-Associated Variants
News & Features
New Targets Identified For Lupus and Rheumatoid Arthritis
Bioinformatics
Single Genetic Variant Associated with Cannabis Abuse
News & Features
Illumina Prevails Against Ariosa in UK Patent Infringement Case
Topics
All
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
News & Features
Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery
Precision Medicine
MGI, Karolinska Institutet Collaborate on Translational Microbiome Research
Bioinformatics
Study of Multiethnic Groups Reveals 27 New Disease-Associated Variants
News & Features
New Targets Identified For Lupus and Rheumatoid Arthritis
Magazine
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 2
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 5, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 5, Issue No. 5
Multimedia
All
Webinars
eBooks
Webinars
In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology
eBooks
Rethinking Rx-Dx Codevelopment
Webinars
Liquid Biopsy and ddPCR: A Match with Quality in Mind
Multimedia
Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Sequencing
Whole Exome Sequencing
Whole Exome Sequencing
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Whole Exome Sequencing
DNAnexus, UPMC, Sutter Health Launch Clinico-Genomic MS Precision Medicine Study
April 15, 2019
Whole Exome Sequencing
Exclusive: A Conversation with David Bentley, VP and Chief Scientist, Illumina
March 30, 2019
Whole Exome Sequencing
UK Biobank Study Reveals Gene Variants with Clinical Implications
March 11, 2019
Whole Exome Sequencing
Geisinger Gets $3.1M NIH Grant to Study Sudden Cardiac Death
March 5, 2019
Whole Exome Sequencing
George Church Startup Nebula Genomics Raises Seed Financing
August 30, 2018
Whole Exome Sequencing
Whole-Exome Sequencing Identifies New Genes Implicated in Alzheimer’s Disease
August 14, 2018
Whole Exome Sequencing
George Church Among Co-Founders of Blockchain Sequencing Startup
February 8, 2018
Whole Exome Sequencing
Liquid Biopsy Enables Whole-Exome Sequencing of Metastatic Tumors in Nearly Half...
November 6, 2017
Whole Exome Sequencing
A Conversation with Heidi Rehm
July 30, 2017
Whole Exome Sequencing
Consortium Explores the Genetics Underlying Tourette Syndrome
May 5, 2017
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1322-218x150.jpeg "Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-218x150.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
